November 10, 2025

FDA Proposes Removal of Box Warnings

The FDA proposed updates to menopausal hormone therapy labeling to reflect current evidence on benefits and risks.

Conexiant

November 10, 2025

Primary Care’s Role in PTSD Treatment

Researchers found that written exposure therapy and SSRIs both reduced PTSD symptoms in primary care, while switching to venlafaxine benefited nonresponders.

Conexiant

November 10, 2025

Predictor of Tobacco Use Identified

Researchers show a risk factor influencing future tobacco use among U.S. youth and young adults.

Conexiant

November 06, 2025

‘Wasteful’? Doctors Call It Essential

Proposed cuts to the Hospital Preparedness Program may limit hospitals’ capacity to manage pandemics, natural disasters, and mass-casualty events affecting U.S. health systems.

KFF Health News

November 06, 2025

Lumateperone Approved for Major Depression

The atypical antipsychotic demonstrated statistically significant improvements over placebo in two phase 3 trials, with separation from placebo emerging within 1 to 2 weeks and 65% of patients achieving remission at 6 months.

Conexiant

November 05, 2025

Does Fasting Influence Focus?

Over 3,400 participants took part in trials testing cognitive outcomes after fasting.

Conexiant

November 05, 2025

Medical Oddities: It Actually Pays To Get Old 

From despair to repair, these studies flip what we thought we knew.

Conexiant

November 05, 2025

Wait Time Equity Elusive in VHA Specialty Care

Over 10 million referrals revealed systemic inequities in access to care.

Conexiant

November 05, 2025

Shame in Medicine—A Quiet Epidemic

A new movement in medicine aims to teach “shame competence,” helping physicians recognize and manage one of the field’s most corrosive yet overlooked emotions.

KFF Health News